INE901L01018
INE901L01018
ALEMBIC PHARMA LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 72.126.100.000 | 65.397.100.000 | 10.3% |
| Cost of Revenue | 23.597.400.000 | 21.369.100.000 | 10.4% |
| Gross Profit | 48.528.700.000 | 44.028.000.000 | 10.2% |
| 40.489.500.000 | 36.677.600.000 | 10.4% | |
| Operating Income | 8.039.200.000 | 7.350.400.000 | 9.4% |
| Pretax Income | 6.939.500.000 | 7.071.800.000 | 1.9% |
| Net Income Common Stockholders | 6.747.700.000 | 5.834.200.000 | 15.7% |
| -- | -- | -- | |
| -- | -- | -- |